Provided is a reducing and/or improving agent for growth impairment induced by the administration of a steroid, said agent being a medicine for reducing and/or improving growth impairment induced by the administration of a steroid during a growth period, and containing at least one type of natriuretic peptide receptor B (NPR-B) agonist as an active component.